These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 10607257)

  • 1. Granulocyte-macrophage colony-stimulating factor enhances the efficacy of hepatitis B virus vaccine in previously unvaccinated haemodialysis patients.
    Kapoor D; Aggarwal SR; Singh NP; Thakur V; Sarin SK
    J Viral Hepat; 1999 Sep; 6(5):405-9. PubMed ID: 10607257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Granulocyte macrophage colony stimulating factor (GM-CSF) induced sero-protection in end stage renal failure patients to hepatitis B in vaccine non-responders.
    Jha R; Lakhtakia S; Jaleel MA; Narayan G; Hemlatha K
    Ren Fail; 2001 Sep; 23(5):629-36. PubMed ID: 11725909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The safety and efficacy of GM-CSF as an adjuvant in hepatitis B vaccination of chronic hemodialysis patients who have failed primary vaccination.
    Evans TG; Schiff M; Graves B; Agosti J; Barritt ML; Garner D; Holley JL
    Clin Nephrol; 2000 Aug; 54(2):138-42. PubMed ID: 10968690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of GM-CSF as an adjuvant to hepatitis B vaccination in patients with chronic renal failure--results of a prospective, randomized trial.
    Singh NP; Mandal SK; Thakur A; Kapoor D; Anuradha S; Prakash A; Kohli R; Agarwal SK
    Ren Fail; 2003 Mar; 25(2):255-66. PubMed ID: 12739832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of granulocyte-macrophage colony-stimulating factor (GM-CSF) on hepatitis B vaccination in haemodialysis patients.
    Hess G; Kreiter F; Kösters W; Deusch K
    J Viral Hepat; 1996 May; 3(3):149-53. PubMed ID: 8871874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune response to hepatitis B vaccine in HIV-infected subjects using granulocyte-macrophage colony-stimulating factor (GM-CSF) as a vaccine adjuvant: ACTG study 5220.
    Overton ET; Kang M; Peters MG; Umbleja T; Alston-Smith BL; Bastow B; Demarco-Shaw D; Koziel MJ; Mong-Kryspin L; Sprenger HL; Yu JY; Aberg JA
    Vaccine; 2010 Aug; 28(34):5597-604. PubMed ID: 20600512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis B virus vaccine in lymphoproliferative disorders: a prospective randomized study evaluating the efficacy of granulocyte-macrophage colony stimulating factor as a vaccine adjuvant.
    Yağci M; Acar K; Sucak GT; Yamaç K; Haznedar R
    Eur J Haematol; 2007 Oct; 79(4):292-6. PubMed ID: 17655695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overcoming HBV immune tolerance to eliminate HBsAg-positive hepatocytes via pre-administration of GM-CSF as a novel adjuvant for a hepatitis B vaccine in HBV transgenic mice.
    Wang X; Dong A; Xiao J; Zhou X; Mi H; Xu H; Zhang J; Wang B
    Cell Mol Immunol; 2016 Nov; 13(6):850-861. PubMed ID: 26166767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Granulocyte-macrophage colony-stimulating factor as an adjuvant to hepatitis B vaccination in maintenance hemodialysis patients.
    Anandh U; Bastani B; Ballal S
    Am J Nephrol; 2000; 20(1):53-6. PubMed ID: 10644869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of GM-CSF in combination with hepatitis B vaccine on revacination of healthy adult non-responders.
    Lin C; Zhu J; Zheng Y; Chen Y; Wu Z; Chong Y; Gao Z
    J Infect; 2010 Apr; 60(4):264-70. PubMed ID: 20138189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of granulocyte macrophage colony stimulating factor on hepatitis-B vaccination in haemodialysis patients.
    Sudhagar K; Chandrasekar S; Rao MS; Ravichandran R
    J Assoc Physicians India; 1999 Jun; 47(6):602-4. PubMed ID: 10999156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Granulocyte macrophage colony-stimulating factor as an adjuvant for hepatitis B vaccination: a meta-analysis.
    Cruciani M; Mengoli C; Serpelloni G; Mazzi R; Bosco O; Malena M
    Vaccine; 2007 Jan; 25(4):709-18. PubMed ID: 16963165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficient haemodialysis improves the response to hepatitis B virus vaccination.
    Kovacic V; Sain M; Vukman V
    Intervirology; 2002; 45(3):172-6. PubMed ID: 12403922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Meta-analysis: the adjuvant role of granulocyte macrophage-colony stimulating factor on immunological response to hepatitis B virus vaccine in end-stage renal disease.
    Fabrizi F; Ganeshan SV; Dixit V; Martin P
    Aliment Pharmacol Ther; 2006 Sep; 24(5):789-96. PubMed ID: 16918882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV viraemia during hepatitis B vaccination shortens the duration of protective antibody levels.
    O'Bryan TA; Rini EA; Okulicz J; Messner O; Ganesan A; Lalani T; Bavaro MF; O'Connell RJ; Agan BK; Landrum ML
    HIV Med; 2015 Mar; 16(3):161-7. PubMed ID: 25586899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peripheral blood dendritic cells and GM-CSF as an adjuvant for hepatitis B vaccination in hemodialysis patients.
    Verkade MA; van de Wetering J; Klepper M; Vaessen LM; Weimar W; Betjes MG
    Kidney Int; 2004 Aug; 66(2):614-21. PubMed ID: 15253714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Response to hepatitis B virus vaccination in haemodialysis patients with and without hepatitis C infection.
    Sorkhi H; Roushan MR; Al Hashemi GH; Dooki MR; Bai S
    East Mediterr Health J; 2008; 14(4):798-803. PubMed ID: 19166162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of granulocyte-macrophage colony-stimulating factor (GM-CSF) as a vaccine adjuvant for hepatitis B virus in patients with HIV infection.
    Sasaki Md; Foccacia R; de Messias-Reason IJ
    Vaccine; 2003 Nov; 21(31):4545-9. PubMed ID: 14575766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of levamisole supplementation on hepatitis B virus vaccination response in hemodialysis patients.
    Sali S; Alavian SM; Hajarizadeh B
    Nephrology (Carlton); 2008 Oct; 13(5):376-9. PubMed ID: 18518938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibody titration and immune response of Iranian beta-thalassemic patients to hepatitis B virus vaccine (booster effect).
    Azarkeivan A; Karimi G; Shaiegan M; Maghsudlu M; Tabbaroki A
    Pediatr Hematol Oncol; 2009 Jun; 26(4):195-201. PubMed ID: 19437322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.